Biotech

  • Home
  • Our Business
  • Biotech

Biotech

image
COVID-19 vaccine investment

Joint venture with EBI for repurpose of vaccine for prevention of COVID-19

Ho Wah Genting Berhad (Bursa stock code:9601), through its wholly-owned subsidiary HWGB Biotech Sdn Bhd signed a joint venture agreement with US-based E-MO Biology Inc. (“EBI”) for the research and development of vaccines, immunological treatment, and diagnostic product development in relation to the COVID-19 virus, followed by the Memorandum of Agreement signed on 06 August 2020.


Details
image
COVID-19 medical device

Wuhan Easy Diagnosis Biomedicine Co. Ltd. (WEBC) COVID-19 (SARS-CoV-2) Nucleic Acid Test Kit

Ho Wah Genting Berhad (“HWGB” or the “Company”) (Bursa Stock Code:9601) is pleased to announce that the nucleic acid test kits manufactured by Wuhan Easydiagnosis Biomedicine Co Ltd (“Wuhan Easydiagnosis”) and authorised for distribution in Malaysia has passed with 100% accuracy an evaluation by the Ministry of Health’s (“MOH”) National Public Health Laboratory (“NPHL”).


Details
image
Disinfectant

D’VIRIA

D’VIRIA Nano CD disinfectant is a revolutionary,advanced delivery system to generate a highly pure aqueous chlorine dioxide solution. D’VIRIA Nano CD disinfectant does not contain any chlorine compounds.D’VIRIA Nano CD disinfectant has removed all known drawbacks, side-effects and by-products known from chlorine dioxide.


Details
image